Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/16/2863512/0/en/Enlivex-Announces-Authorization-from-the-Danish-Regulatory-Agency-for-the-Company-s-Randomized-Controlled-Phase-I-II-Trial-Evaluating-Allocetra-in-Patients-with-Knee-Osteoarthritis.html
https://www.biospace.com/article/enlivex-s-stock-plummets-50-percent-on-phase-ii-sepsis-results-for-cell-therapy-/
https://www.globenewswire.com/news-release/2024/04/11/2861827/0/en/Enlivex-to-Host-Webcast-on-April-12-2024-at-8-30-a-m-Eastern-Time-to-Discuss-Topline-Results-from-Its-Phase-II-Trial-Evaluating-Allocetra-In-Patients-with-Sepsis.html
https://www.globenewswire.com/news-release/2024/04/11/2861472/0/en/Enlivex-Announces-Topline-Results-of-Its-Phase-II-Trial-Evaluating-Allocetra-In-Patients-With-Sepsis.html
https://www.globenewswire.com//news-release/2024/02/07/2825143/0/en/Enlivex-Announces-Issuance-of-New-U-S-Patent-Covering-Allocetra-Cells-and-Their-Manufacturing-Method.html
https://www.globenewswire.com//news-release/2024/01/17/2810641/0/en/Enlivex-Receives-IMOH-Regulatory-Authorization-for-the-Initiation-of-a-Multi-Country-Randomized-Controlled-Phase-I-II-Trial-Evaluating-Allocetra-in-Up-To-160-Patients-with-Moderate.html
https://www.globenewswire.com//news-release/2023/12/20/2799218/0/en/Enlivex-Announces-Completion-of-Enrollment-of-Its-Phase-II-Trial-Evaluating-Allocetra-In-Patients-With-Sepsis.html
https://www.globenewswire.com//news-release/2023/09/11/2740736/0/en/Enlivex-Announces-Reprioritization-Plan-and-Second-Quarter-2023-Financial-Results.html
https://endpts.com/enlivex-halts-oncology-research-lays-off-50-of-staff-moderna-warns-against-trc-capital-mini-tender/
https://www.globenewswire.com//news-release/2023/09/07/2739277/0/en/Enlivex-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html